Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.
Gridelli C, Morgillo F, Favaretto A, de Marinis F, Chella A, Cerea G, Mattioli R, Tortora G, Rossi A, Fasano M, Pasello G, Ricciardi S, Maione P, Di Maio M, Ciardiello F.
Gridelli C, et al. Among authors: de marinis f.
Ann Oncol. 2011 Jul;22(7):1528-1534. doi: 10.1093/annonc/mdq630. Epub 2011 Jan 6.
Ann Oncol. 2011.
PMID: 21212155
Free article.
Clinical Trial.